Filter
1130
Filtered Results: 1130
Text search:
molecular
testing
Featured
Recommendations
156
New Publications
236
Language
Document type
No document type
548
Guidelines
242
Studies & Reports
183
Manuals
58
Strategic & Response Plan
48
Fact sheets
25
Training Material
12
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
70
Western and Central Europe
41
Global
36
Latin America and the Carribbean
31
Africa
27
Eastern Europe
24
Kenya
23
South Africa
20
Tanzania
18
Ethiopia
17
Brazil
14
East and Southern Africa
13
West and Central Africa
13
Sierra Leone
11
Malawi
11
Russia
11
Uganda
10
Rwanda
10
Nigeria
9
Germany
9
Colombia
9
South–East Asia Region
9
Liberia
8
Philippines
8
Zambia
8
Asia
8
Nepal
7
Mozambique
7
Namibia
7
Peru
7
Zimbabwe
6
Indonesia
6
Bangladesh
6
Argentina
6
Senegal
5
Congo, Democratic Republic of
5
Ukraine
5
Myanmar / Burma
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
USA
4
Ghana
4
Pakistan
4
Syria
4
Angola
4
Guinea-Bissau
3
Cambodia
3
Eswatini/ Swaziland
3
Ecuador
3
Botswana
3
El Salvador
3
Chile
3
Vietnam
3
Spain
3
Guinea
2
Burkina Faso
2
Cameroon
2
South Sudan
2
Lebanon
2
Turkey
2
Bolivia
2
Venezuela
2
Tajikistan
2
Georgia
2
Haiti
1
Somalia
1
Jordan
1
Afghanistan
1
Gambia
1
Benin
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Timor Leste/ East Timor
1
North America
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
335
Clinical Guidelines
169
Pharmacy & Technologies
52
Public Health
45
Key Resources
22
Women & Child Health
15
Capacity Building
4
Toolboxes
TB
255
COVID-19
160
AMR
81
HIV
75
NTDs
62
Rapid Response
59
Ebola
32
Mental Health
25
Planetary Health
23
Pharmacy
20
Zika
19
Refugee
14
Polio
12
NCDs
12
Specific Hazards
8
Caregiver
6
Cholera
5
Natural Hazards
4
Health Financing Toolbox
4
Disability
3
Conflict
3
Global Health Education
2
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
At the global, national, and regional levels, there are several guidelines and guides regarding the preparedness, prevention, surveillance, and control of diseases caused by respiratory viruses; most initiatives focus on specific virus events or cases. During the coronavirus disease 2019 (COVID-19) ...
One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence and promote the training of the health workforce, especially pediatric oncology nurses, specialized in nursing care for children and adolescents with cance...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
